Want to see GB:CRTX full AI Analyst Report?
CRTX Stock Chart & Stats
11.50 p
-0.05 p(-0.47%)
At close: 4:00 PM EDT
11.50 p
-0.05 p(-0.47%)
Day’s Range― - ―
52-Week Range8.00 p - 18.50 p
Previous CloseN/A
Volume25.73K
Average Volume (3M)279.49K
Market Cap
£8.91M
Enterprise Value3.72M
Total Cash (Recent Filing)£1.13M
Total Debt (Recent Filing)£0.00
Price to Earnings (P/E)―
Beta0.56
Next Earnings
Sep 23, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield765.96%
Share Statistics
EPS (TTM)-0.05
Shares Outstanding79,185,265
10 Day Avg. Volume168,791
30 Day Avg. Volume279,490
Financial Highlights & Ratios
PEG Ratio0.07
Price to Book (P/B)3.47
Price to Sales (P/S)0.00
P/FCF Ratio-2.49
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Zero Financial LeverageThe absence of financial debt reduces refinancing pressure and avoids interest obligations while the company advances its projects. This provides greater flexibility in allocating available capital, although it does not by itself resolve the need for external funding.
Mineral Project OptionalityA concentrated focus on a defined nickel-copper sulphide project gives the company a clear asset-development pathway rather than an unfocused portfolio. Future value could come from advancing, partnering, monetizing, or developing these mineral interests.
Milestone-driven Corporate ProgressProgress across clinical development, funding support, and regulatory or intellectual-property work can improve execution visibility over the next several months. These milestones provide tangible development markers and may support continued advancement of the company’s programs.
Bears Say
No Established Operating RevenueThe lack of consistent operating revenue means the company has not demonstrated a self-sustaining commercial engine. Its ability to fund exploration, studies, and overhead therefore remains dependent on project monetization or additional external capital.
Persistent Cash BurnSustained negative operating and free cash flow limits internal funding capacity and increases reliance on financing or other capital sources. The worsening 2025 burn indicates that continued activity may consume cash before projects generate dependable operating receipts.
Deep And Volatile LossesDeep losses and limited operating leverage weaken the company’s financial foundation and make earnings recovery difficult to assess. Continued expense absorption without meaningful revenue leaves equity returns negative and can constrain long-term capital allocation.
Amur Minerals News
CRTX FAQ
What was Amur Minerals Corporation’s price range in the past 12 months?
Amur Minerals Corporation lowest share price was 8.00 p and its highest was 18.50 p in the past 12 months.
What is Amur Minerals Corporation’s market cap?
Amur Minerals Corporation’s market cap is £8.91M.
When is Amur Minerals Corporation’s upcoming earnings report date?
Amur Minerals Corporation’s upcoming earnings report date is Sep 23, 2026 which is in 11 days.
How were Amur Minerals Corporation’s earnings last quarter?
Amur Minerals Corporation released its earnings results on Jun 26, 2026. The company reported -0.024 p earnings per share for the quarter.
Is Amur Minerals Corporation overvalued?
According to Wall Street analysts Amur Minerals Corporation’s price is currently Overvalued.
Does Amur Minerals Corporation pay dividends?
Amur Minerals Corporation pays a Notavailable dividend of 288 p which represents an annual dividend yield of 765.96%. See more information on Amur Minerals Corporation dividends here
What is Amur Minerals Corporation’s EPS estimate?
Amur Minerals Corporation’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Amur Minerals Corporation have?
Amur Minerals Corporation has 79,185,265 shares outstanding.
What happened to Amur Minerals Corporation’s price movement after its last earnings report?
Amur Minerals Corporation reported an EPS of -0.024 p in its last earnings report. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Amur Minerals Corporation?
Currently, no hedge funds are holding shares in GB:CRTX
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Amur Minerals Corporation
CRISM Therapeutics Corporation is dedicated to developing innovative drug delivery systems that enhance the effectiveness of cancer medications targeting solid tumors. Their primary offering, ChemoSeed, is designed for direct insertion into a tumor or the surgical site post-tumor removal, ensuring that therapeutic concentrations of chemotherapy agents are precisely localized to the cancerous tissue. This technology finds particular application in treating gliomas, a form of brain tumor. The company was established in 2016 and is headquartered in Road Town, British Virgin Islands.